MLchartDataset catalogue

p53 peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-015749

A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein.

Table 1. Record
IdentifierMLC-T-ONC-015749
FieldOncology and biomedicine
Synonymsp53:264-272 peptide
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015749",
  "term": "p53 peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A peptide-based cancer vaccine composed of amino acids 264 to 272 of the wild-type protein encoded by the P53 gene. p53 peptide vaccine may elicit an HLA-A2.1-restricted cytotoxic T lymphocyte immune response against tumor cells that overexpress p53 protein.",
  "synonyms": [
    "p53:264-272 peptide"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/p53-peptide-vaccine/"
}

Record 12,476 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.